Find clinical trials for Acute Myeloid Leukemia (AML) in Tampa, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Tampa, FL, USA:
CLN-049-001 is a Phase 1, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...
Phase 1
Tampa, Florida, United States and 10 other locations
This Phase 1, multicenter, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (...
Phase 1
Tampa, Florida, United States and 8 other locations
The primary purpose of Phase 1 is to assess the doses studied under Phase 1 (Dose Escalation) Arm A and identify the recommended dose (RD) for furthe...
Phase 1, Phase 2
Tampa, Florida, United States and 6 other locations
preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clin...
Phase 1
Tampa, Florida, United States and 6 other locations
The purpose of this research study is to see if people whose Acute myeloid leukemia (AML) is being successfully t...
Phase 2
Tampa, Florida, United States
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Tampa, Florida, United States and 88 other locations
This multicenter, open-label phase II study combines CLAG-based therapy with or without venetoclax in patients with relapsed or refractory (R/R) acute...
Phase 2
Tampa, Florida, United States and 1 other location
This is an open-label, multi-center Phase 1 study of LY3410738, an oral, covalent isocitrate dehydrogenase (IDH) inhibitor, in patients with IDH1 and...
Phase 1
Tampa, Florida, United States and 36 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Tampa, Florida, United States and 226 other locations
(CAR) T cells), in adult patients with relapsed or refractory acute myeloid leukemia (AML), Minimal Residual Dise ...
Phase 1
Tampa, Florida, United States and 1 other location
Clinical trials
Research sites
Resources
Legal